Novartis Venture Fund — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
Mediar Therapeuticsmediartx.cominNov 2022
Mediartx develops novel therapies for patients with fibrotic diseases.
BiotechMedical DevicesBoston, US
Rahul Ballal, PhD(CEO)Paul Yaworsky, PhD(CSO)inRahul Ballal(Executive Officer, Director)Brian Hubbard(Director)Stacey Brenner(Executive Officer)David de Graaf(Director)
Board seatAnja Koenig· per SEC Form D
Co-investorsLongwood FundMission BiocapitalOno Venture Investment, Inc.Pfizer Venture InvestmentsShangBay Capital LLCSofinnova Partners+2 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.